MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Using Human Neural Tissue Methylation to Decipher Epigenetic Characteristics and Cell Type Pathologies in Huntington’s Disease

    A. Glaser, J. Levy, Z. Zhang, L. Salas (Hanover, USA)

    Objective: This study combines methylation data from the two largest EWAS studies in Huntington's Disease (HD) human brain tissue [1,2]. Combined, this study yields the…
  • MDS Virtual Congress 2021

    DNA methylation of CDKN2B/CDKN2B-AS1 enhancer in Huntington’s disease and lung cancer

    I. Goncharova, E. Bragina, D. Gomboeva, N. Babushkina, A. Markov, M. Nazarenko, M. Nikitina, V. Alifirova, N. Zhukova, S. Illarioshkin, V. Puzyrev (Tomsk, Russian Federation)

    Objective: The aim of this study was to evaluate the DNA methylation of the CDKN2B/CDKN2B-AS1 enhancer with Huntington's disease and lung cancer. Background: Phenomenon of…
  • MDS Virtual Congress 2021

    Fine-grained prediction of Huntington’s disease stage using a meta-model approach

    M. Kohli, S. Gregory, R. Scahill, S. Tabrizi, D. Alexander, P. Wijeratne (London, United Kingdom)

    Objective: We developed a machine learning (ML) framework that facilitates prediction of individual-level Huntington’s disease (HD) stage. The proposed meta-model approach classifies participants according to…
  • MDS Virtual Congress 2021

    Atypical gait in a patient with Huntington’s Disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD

    H. Leal Bailey, K. Block, E. Furr-Stimming, S. Chandra (Houston, USA)

    Objective: We describe a case of Huntington’s disease (HD) associated chorea and concurrent functional movement disorder (FMD). Background: HD is a neurodegenerative disorder characterized by…
  • MDS Virtual Congress 2021

    Cost of Predictive Genetic Testing for Huntington’s Disease at Centers of Excellence in the US

    M. Massey, T. Orem, V. Sung (Birmingham, USA)

    Objective: To characterize the cost of Huntington’s disease predictive genetic testing at Centers of Excellence in the US. Background: Despite the availability of predictive genetic…
  • MDS Virtual Congress 2021

    Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

    E. Mcdonnell, Y. Wang, K. Marder (New York, USA)

    Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
  • MDS Virtual Congress 2021

    Using patient-reported quality of life outcomes to assess the validity of smartphone-based remote assessment of motor and cognitive performance in manifest Huntington’s disease patients

    F. Riese, J. Rennig, F. Lipsmeier, A. Bamdadian, S. Schobel, C. Gossens, P. Weydt, J. Dorn, E. Wild, D. Trundell, C. Simillion, M. Lindemann (Basel, Switzerland)

    Objective: Explore associations between remote monitoring of cognitive and motor functions and digitally administered, self-assessed EuroQol 5-dimension 5-level (EQ-5D-5L) items. Background: Assessment of cognitive and…
  • MDS Virtual Congress 2021

    Nonmotor Symptoms in Huntington disease in relation to the Diagnostic Confidence Level

    N. Rocha, M. Edmondson, C. Testa, J. Patino, M. Rossetti, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To analyze HD gene carriers’ performance on cognitive and behavioral tests according to the Diagnostic Confidence Level (DCL). Background: The diagnosis of manifest HD…
  • MDS Virtual Congress 2021

    An unusual case of belly dancer´s dyskinesia in a man with Huntington disease

    S. Rodriguez Navas, E. García Roldán, D. Macías-García, A. Vilches Guerra, FJ. Palomar-Simón, F. Carrillo, M. Ruiz-Veguilla, P. Mir (Sevilla, Spain)

    Objective: Our objective was to describe the presence of Belly Dancer’s dyskinesia (BBD) in a Huntington`s Disease (HD) patient with predominantly behavorial symptoms. Background: BDD…
  • MDS Virtual Congress 2021

    Characterizing US Healthcare Delivery in Huntington’s Disease (HD)

    L. Seeberger, J. Corey-Bloom, M. O'Brien, P. Chen, B. Griffin, D. Schlang, D. Slowiejko (Aurora, USA)

    Objective: The HD-Net research survey aimed to assess care patterns among practice types in the U.S., to identify gaps in the provision of HD care.…
  • « Previous Page
  • 1
  • …
  • 719
  • 720
  • 721
  • 722
  • 723
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley